Ariad Pharmaceuticals Inc completes follow-on

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Cambridge, Mass. Business: Cancer Date completed: 10/26/10 Type: Follow-on Raised: $59.2 million Shares: 16 million Price: $3.70 Shares after offering: 126.9 ...